CP-690,550 (tofacitinib) ( DrugBank: Tofacitinib )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1
107	若年性特発性関節炎	1

46. 悪性関節リウマチ

---

臨床試験数 : 4,356 /  薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01745055 (ClinicalTrials.gov)	April 2005	4/12/2012	Co-Administration Of Methotrexate And CP-690,550	A Phase 1, Open Label Study Of The Pharmacokinetics Of Multiple Doses Of Oral CP-690,550 And Single Doses Of Oral Methotrexate In Rheumatoid Arthritis Subjects	Rheumatoid Arthritis	Drug: CP-690,550 (tofacitinib);Drug: Methotrexate (MTX)	Pfizer	NULL	Completed	18 Years	70 Years	All	12	Phase 1	United States

107. 若年性特発性関節炎

---

臨床試験数 : 447 /  薬物数 : 297 - (DrugBank : 57) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 146

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02592434 (ClinicalTrials.gov)	June 10, 2016	14/8/2015	Efficacy Study Of Tofacitinib In Pediatric JIA Population	EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS	Juvenile Idiopathic Arthritis	Drug: CP-690,550 (tofacitinib);Other: placebo	Pfizer	NULL	Completed	2 Years	17 Years	All	225	Phase 3	United States;Argentina;Australia;Belgium;Brazil;Canada;Israel;Mexico;Poland;Russian Federation;Spain;Turkey;Ukraine;United Kingdom;Chile;Germany;South Africa;Switzerland